ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Revenue

In the year 2024, ProQR Therapeutics had annual revenue of 19.55M EUR with 196.41% growth. ProQR Therapeutics had revenue of 4.44M in the quarter ending December 31, 2024, with 35.29% growth.

• Revenue (ttm): 19.55M EUR
• Revenue Growth: +196.41%
• P/S Ratio: 8.47
• Revenue / Employee: 117,670 EUR
• Employees: 166
• Market Cap: 199.90M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.55M	12.95M	196.41%
Dec 31, 2023	6.59M	2.24M	51.27%
Dec 31, 2022	4.36M	1.98M	83.31%
Dec 31, 2021	2.38M	1.35M	131.10%
Dec 31, 2020	1.03M	-904.00K	-46.77%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.